Core Viewpoint - Rosen Law Firm is reminding investors who purchased Stride, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the Stride securities is from October 22, 2024, to October 28, 2025, and the lead plaintiff deadline is January 12, 2026 [1]. - Investors who purchased Stride securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has consistently ranked highly in securities class action settlements since 2013 [3]. Group 3: Allegations Against Stride, Inc. - The lawsuit alleges that Stride made misleading statements regarding its products and services, inflating enrollment numbers, cutting staff costs excessively, and failing to comply with requirements, which led to investor damages when the truth was revealed [4].

Core Viewpoint - A class action lawsuit has been filed against DeFi Technologies, Inc. for misleading statements regarding its financial performance and business operations during the specified Class Period from May 12, 2025, to November 14, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that DeFi Technologies made false and misleading statements about delays in executing its DeFi arbitrage strategy, which is a key revenue driver [5]. - It is alleged that the company understated the competition it faced from other digital asset treasury companies, impacting its ability to execute its strategy [5]. - The lawsuit indicates that DeFi Technologies was unlikely to meet its previously issued revenue guidance for the fiscal year 2025 due to these issues [5]. Group 2: Investor Information - Investors who purchased DeFi Technologies securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [3][6]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - A class action lawsuit has been filed against Blue Owl Capital Inc. for misleading statements regarding its financial health and liquidity issues during the specified Class Period from February 6, 2025, to November 16, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Blue Owl made false or misleading statements and failed to disclose significant pressures on its asset base due to business development companies (BDC) redemptions, leading to undisclosed liquidity issues [5]. - It is alleged that Blue Owl was likely to limit or halt redemptions of certain BDCs, and that the defendants downplayed the severity of the negative impacts, resulting in materially misleading statements about the company's business and prospects [5]. Group 2: Investor Information - Investors who purchased Blue Owl securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors can visit the provided link or contact the law firm for more information [3][6]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Western Alliance Bancorporation due to allegations of materially misleading business information [1] Group 1: Investigation and Legal Action - Rosen Law Firm is preparing a class action to seek recovery of investor losses for those who purchased Western Alliance Bancorporation securities [2] - On October 16, 2025, Western Alliance Bancorporation disclosed a lawsuit against Cantor Group V LLC, alleging fraud related to collateral loans, which resulted in a 10.88% drop in the company's stock price on the same day [3] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has consistently ranked in the top 4 for securities class action settlements since 2013 [4]

Core Viewpoint - Rosen Law Firm is encouraging investors of StubHub Holdings, Inc. to secure legal counsel before the January 23, 2026 deadline for a securities class action lawsuit related to the company's September 2025 IPO [2][4]. Group 1: Legal Action Details - Investors who purchased StubHub common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 23, 2026 [4]. - The lawsuit claims that the Registration Statement was materially false and misleading, omitting significant information about changes in payment timing to vendors and its adverse impact on free cash flow [6]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company and being ranked No. 1 for securities class action settlements in 2017 [5]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [5]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation in the field [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Jayud Global Logistics Ltd. to secure legal counsel before the January 20, 2026 deadline for a securities class action lawsuit related to alleged misleading statements and fraudulent activities during the Class Period from April 21, 2023, to April 30, 2025 [1][5]. Group 1: Legal Action Details - Investors who purchased Jayud securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 20, 2026 [3]. - The lawsuit alleges that Jayud made materially false statements and failed to disclose significant information regarding a fraudulent stock promotion scheme and insider trading activities [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Many attorneys at Rosen Law Firm have received recognition from Lawdragon and Super Lawyers, highlighting the firm's expertise in this area [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Alvotech due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation Details - The investigation is prompted by a press release from Alvotech on November 2, 2025, which announced that the U.S. FDA issued a complete response letter (CRL) for Alvotech's Biologics License Application (BLA) for AVT05, indicating deficiencies that must be resolved before approval [3]. - Following the announcement of the CRL, Alvotech's stock price experienced a significant decline, falling 34% on November 3, 2025, and nearly 4% on November 4, 2025 [3]. Group 2: Class Action Information - Investors who purchased Alvotech securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees or costs due to a contingency fee arrangement [2]. - Interested investors can join the prospective class action by visiting the provided link or contacting the law firm directly for more information [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and consistently ranking among the top firms for securities class action settlements since 2013 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Stride, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the Stride securities is from October 22, 2024, to October 28, 2025, and the lead plaintiff deadline is January 12, 2026 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [2][5]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [3]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3]. Group 3: Allegations Against Stride, Inc. - The lawsuit alleges that Stride made misleading statements regarding its products and services to educational institutions during the Class Period [4]. - Stride is accused of inflating enrollment numbers, excessively cutting staff costs, ignoring compliance requirements, and losing enrollments, which led to investor damages when the truth was revealed [4].

Core Viewpoint - Rosen Law Firm is encouraging investors of Perrigo Company plc to secure legal counsel before the January 16, 2026 deadline for a securities class action lawsuit related to the company's performance during the specified class period [1][2]. Group 1: Class Action Details - Investors who purchased Perrigo securities between February 27, 2023, and November 4, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 16, 2026 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Allegations Against Perrigo - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business acquired from Nestlé, which suffered from significant underinvestment [5]. - It is claimed that Perrigo needed to make substantial capital and operational expenditures beyond its stated cost estimates to address issues in the infant formula business [5]. - The lawsuit also points out significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results, including earnings and cash flow [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased aTyr Pharma, Inc. common stock during the specified Class Period of the upcoming lead plaintiff deadline on December 8, 2025 [1]. Group 1: Class Action Details - Investors who bought aTyr Pharma common stock between January 16, 2025, and September 12, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors can visit the provided link or contact the law firm for more information [3][6]. - A lead plaintiff must file a motion with the Court by December 8, 2025, to represent other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in this area [4]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has consistently ranked highly in terms of settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [4]. Group 3: Case Background - The complaint alleges that aTyr Pharma provided misleading statements regarding the efficacy of its drug Efzofitimod, particularly concerning its ability to allow patients to taper steroid usage completely [5]. - The lawsuit claims that when the true information became public, investors suffered damages due to the misleading nature of the statements made by the company [5].